Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06962137 |
| Title | Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer (RAINSPOT) |
| Acronym | RAINSPOT |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Universitaire Ziekenhuizen KU Leuven |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UZA | Antwerp | Belgium | Details | |||
| Cliniques Universitaires Saint-Luc Brussels | Brussels | Belgium | Details | |||
| HUB | Brussels | Belgium | Details | |||
| UZ Gent | Ghent | Belgium | Details | |||
| UZ Leuven | Leuven | 3000 | Belgium | Details | ||
| AZ Delta Roeselare | Roeselare | Belgium | Details |